North America Cancer Diagnostics Market Analysis, Company Profiles, Size, Share, Growth, Trends and Forecast to 2024

  • ID: 4435657
  • Report
  • Region: America, North America, United States
  • 350 pages
  • Data Bridge Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • GE Healthcare
  • Hologic, Inc
  • Illumina, Inc.
  • QIAGEN
  • Roche Diagnostics
  • MORE
The North America cancer diagnostics market is accounted to reach USD 17.72 billion by 2024 from USD 7.59 billion in 2016, it is growing at a CAGR of 11.2% in the forecast period 2017 to 2024.

The major factors driving the growth of this market are the technological advancement in the field of early detection of cancer and high investment in cancer research by North America.

The key market players for North America cancer diagnostics Market are listed below:
  • GE Healthcare
  • Siemens Healthcare GmbH
  • Hologic, Inc
  • Becton, Dickinson & Company.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Roche Diagnostics
  • Abbott Laboratories, Inc.
  • QIAGEN
The market is further segmented into.
  • Type
  • Application
  • Technology
  • End User
  • Geography
The North America cancer diagnostics market is segmented on the basis of technology, application and geography. The North America cancer diagnostics market is segmented into 2 types, namely platform based and instrument based.

Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.

Based on application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

Based on geography, the North America cancer diagnostics market is segmented into 11 geographical regions, such as:
  • U.S.
  • Mexico
  • Canada
Covered in this Report

The report covers the present scenario and the growth prospects of the North America Cancer Diagnostics Market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • GE Healthcare
  • Hologic, Inc
  • Illumina, Inc.
  • QIAGEN
  • Roche Diagnostics
  • MORE
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Overview of North America Cancer Diagnostics Market
1.4. Currency and Pricing
1.5. Limitation
1.6. Markets Covered

2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered for the Study
2.4. Currency and Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. Market Overview
3.1. Drivers
3.1.1. Growth of Aging Population and Rising Prevalence of Cancer
3.1.2. Government Initiatives for Funding and Awareness About Cancer
3.1.3. Key Players Focusing on Strategic Decisions to Gain Market Share
3.1.4. Increasing Prevelance of Cancer
3.2. Restraints
3.2.1. Stringent Reulations Imposed by International and Local Authorities
3.2.2. Shortage of Skilled and Trained Professionals
3.3. Opportunities
3.3.1. Nanotechnology: Forthcoming Revolution in Cancer Diagnosis
3.3.2. Artificial Intelligence and the Imminent Health Revolution
3.3.3. Growing Medical Tourism in Asia
3.4. Challenges
3.4.1. Increasing Rivalry Among the Competitors
3.4.2. Poor Access to Cancer Detection and High Treatment Cocts in Lower Income Countries

4. Premium Insights

5. Executive Summary

6. North America Cancer Diagnostics Market, by Technology
6.1. Overview
6.2. Platform Based
6.2.1. Polymerase Chain Reaction(Pcr)
6.2.2. in Situ Hybridization (Ish)
6.2.3. Immunohistochemistry(Ihc)
6.2.4. Next Generation Sequencing (Ngs)
6.2.5. Dna Microarrays
6.2.6. Flow Cytometry
6.3. Instrument Based
6.3.1. Imaging
6.3.1.1. Magentic Resonance Imaging (Mri)
6.3.1.2. Ct(Computed Tomography)
6.3.1.3. Positron Emission Tomography- Computed Tomography (Pet-Ct)
6.3.1.4. Mammography
6.3.1.5. Ultrasound
6.3.2. Biopsy

7. North America Cancer Diagnostics Market, by Application
7.1. Overview
7.2. Lung Cancer
7.3. Breast Cancer
7.4. Colorectal Cancer
7.5. Melanoma
7.6. Others

8. North America Cancer Diagnostics Market, by Geography
8.1. Overview
8.2. North America Cancer Diagnostics Market
8.2.1. U.S.Cancer Diagnostics Market
8.2.2. Canada Cancer Diagnostics Market
8.2.3. Mexico Cancer Diagnostics Market

9. North America Cancer Diagnostics Market, Company Landscape
9.1. Company Share Analysis: North America Cancer Diagnostics Imaging Market
9.2. Company Share Analysis: North America Cancer Diagnostics Platform Based Market

10. Company Profiles
10.1. C. R. Bard, Inc.
10.1.1. Company Overview
10.1.2. Revenue Analysis
10.1.3. Product Portfolio
10.1.4. Recent Developments
10.2. Illumina, Inc.
10.2.1. Company Overview
10.2.2. Revenue Analysis
10.2.3. Recent Developments
10.2.4. Product Portfolio
10.3. Qiagen
10.3.1. Company Overview
10.3.2. Revenue Analysis
10.3.3. Recent Developments
10.3.4. Product Portfolio
10.4. Abbott
10.4.1. Company Overview
10.4.2. Revenue Analysis
10.4.3. Recent Developments
10.4.4. Product Portfolio
10.5. Siemens Healthcare Gmbh
10.5.1. Company Overview
10.5.2. Revenue Analysis
10.5.3. Recent Developments
10.5.4. Product Portfolio
10.6. Agilent Technologies
10.6.1. Company Overview
10.6.2. Revenue Analysis
10.6.3. Product Portfolio
10.6.4. Recent Developments
10.7. Thermo Fisher Scientific Inc.
10.7.1. Company Overview
10.7.2. Revenue Analysis
10.7.3. Product Portfolio
10.7.4. Recent Developments
10.8. Becton, Dickinson and Company
10.8.1. Company Overview
10.8.2. Revenue Analysis
10.8.3. Product Portfolio
10.8.4. Recent Developments
10.9. Ge Healthcare
10.9.1. Company Overview
10.9.2. Revenue Analysis
10.9.3. Product Portfolio
10.9.4. Recent Developments
10.10. F. Hoffmann-La Roche Ltd
10.10.1. Company Overview
10.10.2. Revenue Analysis
10.10.3. Product Portfolio
10.10.4. Recent Developments
10.11. Hologic Inc.
10.11.1. Company Overview
10.11.2. Revenue Analysis
10.11.3. Recent Developments
10.11.4. Product Portfolio
10.12. Koninklijhe Philips N.V.
10.12.1. Company Overview
10.12.2. Revenue Analysis
10.12.3. Product Portfolio
10.12.4. Recent Developments

11. Related Reports

List of Tables
Table 1 North America Cancer Diagnostics Market, by Country, 2015 - 2024 (USD Million)
Table 2 North America Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 3 North America Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 4 North America Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 5 North America Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 6 North America Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 7 U.S. Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 8 U.S. Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 9 U.S. Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 10 U.S. Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 11 U.S. Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 12 Canada Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 13 Canada Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 14 Canada Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 15 Canada Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 16 Canada Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 17 Mexico Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 18 Mexico Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 19 Mexico Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 20 Mexico Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 21 Mexico Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)

List of Figures
Figure 1 North America Cancer Diagnostics Market Snapshot (2017)
Figure 2 North America Cancer Diagnostics Market, by Country (2016)
Figure 3 North America Cancer Diagnostics Market: by Country (2017)
Figure 4 North America Cancer Diagnostics Market by Country (2016 & 2024)
Figure 5 North America Cancer Diagnostics Market, by Technology (2017 & 2024)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GE Healthcare
  • Siemens Healthcare GmbH
  • Hologic, Inc
  • Becton, Dickinson & Company.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Roche Diagnostics
  • Abbott Laboratories, Inc.
  • QIAGEN
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll